AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie restructuring Reserve Cash Payments [legacy through FY20Q1] ($M) ($M)
Form 10-Q / 10-K Restructuring Note
Latest, Q1 2020
38
Period ended Mar 31, 2020
Change on a year earlier
-13.6%
44 in Q1 2019
History
9 quarters
Since Q1 2018
Sources
8
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring Reserve Cash Payments [legacy through FY20Q1] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2020 | Mar 31, 2020 | 38 | -13.6% | Form 10-Q (filed 2020-05-08) ↗ |
| Q4 2019 | Dec 31, 2019 | 45 | +246.2% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 53 | +341.7% | Form 10-Q (filed 2019-11-06) ↗ |
| Q2 2019 | Jun 30, 2019 | 36 | +157.1% | Form 10-Q (filed 2019-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 44 | +528.6% | Form 10-Q (filed 2019-05-03) ↗ |
| Q4 2018 | Dec 31, 2018 | 13 | – | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2018 | Sep 30, 2018 | 12 | – | Form 10-Q (filed 2018-11-07) ↗ |
| Q2 2018 | Jun 30, 2018 | 14 | – | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 7 | – | Form 10-Q (filed 2018-05-04) ↗ |
Cite this data
StockData. (2026). AbbVie Restructuring Reserve Cash Payments [legacy through FY20Q1] ($M) ($M), quarterly Q1 2018–Q1 2020 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/restruct_paid_leg
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.